These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38236483)

  • 1. A physics-informed deep learning framework for modeling of coronary in-stent restenosis.
    Shi J; Manjunatha K; Behr M; Vogt F; Reese S
    Biomech Model Mechanobiol; 2024 Apr; 23(2):615-629. PubMed ID: 38236483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of optical coherence tomography-derived neointimal tissue morphology on development of very late in-stent restenosis.
    Fujii K; Otsuji S; Yamamoto W; Takiuchi S; Ishibuchi K; Tamaru H; Kakishita M; Ibuki M; Hasegawa K; Ishii R; Nakabayashi S; Higashino Y
    Catheter Cardiovasc Interv; 2020 Oct; 96(4):E398-E405. PubMed ID: 32077557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Prediction Model Construction of Drug-Coated Balloon Combined with Cutting Balloon Angioplasty in the Treatment of Drug-Eluting Stent In-Stent Restenosis.
    Wu H; Yu T; Fan T; Liao W
    Comput Math Methods Med; 2022; 2022():9832622. PubMed ID: 36238492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of optical coherence tomography of early and very late stent restenosis after drug-eluting stent implantation].
    Liu ZJ; Shi B; Deng CC; Xu GX; Zhao RZ; Shen CY; Wang ZL; Liu HL
    Zhonghua Yi Xue Za Zhi; 2017 Jun; 97(23):1778-1783. PubMed ID: 28647998
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of in-stent neointimal tissue components following drug-eluting stent implantation according to the phase of restenosis using a 40-MHz intravascular ultrasound imaging system.
    Araki T; Nakamura M; Sugi K
    J Cardiol; 2014 Dec; 64(6):423-9. PubMed ID: 24794755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Optical coherence tomographic analysis of in-stent neoatherosclerosis in lesions with restenosis after drug-eluting stent implantation].
    Liu ZJ; Shi B; Deng CC; Xu GX; Zhao RZ; Shen CY; Wang ZL; Liu HL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Jan; 46(1):44-49. PubMed ID: 29374937
    [No Abstract]   [Full Text] [Related]  

  • 7. Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis: Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials.
    Alfonso F; Pérez-Vizcayno MJ; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Melgares R; Mainar V; Moreno R; Domínguez A; Sanchís J; Bethencourt A; Moreu J; Cequier A; Martí V; Otaegui I; Bastante T; Gonzalo N; Jiménez-Quevedo P; Cárdenas A; Fernández C;
    Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27412868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-stent restenosis assessed with frequency domain optical coherence tomography shows smooth coronary arterial healing process in second-generation drug-eluting stents.
    Kajiya T; Yamaguchi H; Takaoka J; Fukunaga K; Arima R; Miyamura A; Ninomiya T; Atsuchi N; Atsuchi Y; Terashima M; Kaneda H; Ohishi M
    Singapore Med J; 2019 Jan; 60(1):48-51. PubMed ID: 29632955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of in-stent neoatherosclerosis and tissue characteristics between early and late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study.
    Sabbah M; Kadota K; El-Eraky A; Kamal HM; Abdellah AT; El Hawary A
    Int J Cardiovasc Imaging; 2017 Oct; 33(10):1463-1472. PubMed ID: 28444549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-stent Restenosis.
    Lee MS; Banka G
    Interv Cardiol Clin; 2016 Apr; 5(2):211-220. PubMed ID: 28582205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.
    Almalla M; Pross V; Marx N; Hoffmann R
    Coron Artery Dis; 2012 Nov; 23(7):492-6. PubMed ID: 22990414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological effect on drug distribution and vascular healing via paclitaxel-coated balloon technology in drug eluting stent restenosis swine model.
    Li Y; Tellez A; Rousselle SD; Dillon KN; Garza JA; Barry C; Granada JF
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):89-98. PubMed ID: 26613810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractory In-Stent Restenosis: Improving Outcomes by Standardizing Our Approach.
    Waksman R; Iantorno M
    Curr Cardiol Rep; 2018 Oct; 20(12):140. PubMed ID: 30350271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-Eluting Stent Restenosis: Modern Approach to a Classic Challenge.
    Donisan T; Madanat L; Balanescu DV; Mertens A; Dixon S
    Curr Cardiol Rev; 2023; 19(3):e030123212355. PubMed ID: 36597603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for revascularization and in-stent restenosis in patients with triple-vessel disease after second-generation drug-eluting stent implantation: a retrospective analysis.
    Zeng M; Yan X; Wu W
    BMC Cardiovasc Disord; 2021 Sep; 21(1):446. PubMed ID: 34535088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary computed tomography angiographic detection of in-stent restenosis via deep learning reconstruction: a feasibility study.
    Kawai H; Motoyama S; Sarai M; Sato Y; Matsuyama T; Matsumoto R; Takahashi H; Katagata A; Kataoka Y; Ida Y; Muramatsu T; Ohno Y; Ozaki Y; Toyama H; Narula J; Izawa H
    Eur Radiol; 2024 Apr; 34(4):2647-2657. PubMed ID: 37672056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference in neointimal appearance between early and late restenosis after sirolimus-eluting stent implantation assessed by optical coherence tomography.
    Ino Y; Kubo T; Kitabata H; Ishibashi K; Tanimoto T; Matsuo Y; Shimamura K; Shiono Y; Orii M; Komukai K; Yamano T; Yamaguchi T; Hirata K; Tanaka A; Mizukoshi M; Imanishi T; Akasaka T
    Coron Artery Dis; 2013 Mar; 24(2):95-101. PubMed ID: 23363984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
    El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A
    Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
    Rittger H; Wöhrle J; Brachmann J; Hohenforst-Schmidt W; Schlundt C; Lonke S; von Cranach M; Markovic S; Achenbach S; Waliszewski M
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):529-534. PubMed ID: 26893095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents.
    Rathore S; Kinoshita Y; Terashima M; Katoh O; Matsuo H; Tanaka N; Kimura M; Tsuchikane E; Nasu K; Ehara M; Asakura K; Asakura Y; Suzuki T
    EuroIntervention; 2010 Feb; 5(7):841-6. PubMed ID: 20142201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.